Gregg S. Day, MD, MSc, MSCI, FAAN
Mayo Clinic Jacksonville
Dr. Gregg S. Day is an Associate Professor, Director of the Division of Behavioral Neurology, and Vice Chair of Research within the Department of Neurology at Mayo Clinic in Florida. His research is supported by the National Institute on Aging and focuses on improving the clinical diagnosis, characterization, and treatment of individuals with common and uncommon causes of dementia, including neurodegenerative and autoimmune-mediated causes of rapid progressive dementia. Dr. Day is a project PI of the ExTINGUISH Trial—the first multisite randomized controlled trial for patients with anti-NMDAR encephalitis—and PI of the longitudinal Bio-RaPID study, focused on deciphering that patient- and disease specific contributors to rapidly progressive Alzheimer disease and related dementias.